Supporting and promoting innovative, fast-to-patient drug discovery

Posted on: 21/08/2017

The Medicines Discovery Catapult can help you develop the market and your technology in line with the UK Life Sciences Industrial Strategy.

The Medicines Discovery Catapult is a national centre of applied research and development expertise which promotes and supports innovative, fast-to-patient drug discovery in the UK through collaborative projects across the community.

The Catapult’s community includes contract research organisations (CROs), biotechs, medical charities, technology and pharma companies. With their¬†facilities and expertise, the Catapult enables the sector to solve common problems, de-risk IP and create new products and services.

They are hosting a webinar on Tuesday 10th October 2017, 10:30 Р11:30 , to provide CROs with an opportunity to learn more about the Catapult. They are also keen to hear about your priorities and how you think the Catapult can best support your work. They are inviting CROs from across areas of expertise to take part in the webinar, including companies specialising in:

  • analytical
  • in vitro
  • pharmacology
  • in silico and analytics
  • discovery services
  • early development services
  • diagnostics

You can register for the webinar here.

If you would like to discuss innovation opportunities for medicines discovery with KTN please contact Dr Sarah Goulding (Specialist, Medicines and Advanced Therapies) or Alexander Henzing (Knowledge Transfer Manager, Bioinformatics).

Share this article


Connect with Innovate UK Business Connect

Join Innovate UK Business Connect's mailing list to receive updates on funding opportunities, events and to access Innovate UK Business Connect's deep expertise. Please check your email to confirm your subscription and select your area(s) of interest.